At 6.6x trailing earnings and 8.4x forward earnings, HCI is priced like a no-growth or structurally impaired insurer despite a 0.4 forward PEG ratio that signals aggressive earnings expansion relative to price. The spread between a 6.6 P/E and a forward estimate implying material EPS acceleration suggests the market either distrusts the $24.58 EPS next year figure or is pricing in volatility typical of Property & Casualty underwriting cycles. A 27.60% operating margin and 26.70% ROIC are not distressed metrics—they are capital-efficient and profitable—yet the stock trades at just 1.9x book and 2.1x sales. The absence of an Altman Z-Score leaves balance sheet safety unquantified, but on pure earnings power versus valuation, this screens as statistically mispriced to the upside.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.